Clinical Trials Logo

Acute Bleeding clinical trials

View clinical trials related to Acute Bleeding.

Filter by:
  • None
  • Page 1

NCT ID: NCT02885545 Withdrawn - Clinical trials for Chronic Kidney Disease

The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial

STOP-HARM
Start date: September 2016
Phase: Phase 4
Study type: Interventional

Patients with severe chronic kidney disease (CKD) who develop atrial fibrillation are at high risk for stroke. The use of blood thinking medication in dialysis patients is controversial and warfarin carries a serious risk for major bleeding. The Watchman device may be an ideal therapy for this population as after implantation it allows for the discontinuation of blood thinners, thereby reducing the risk of bleeding.